STXS - A Podcast from Joe's Pros

Stereotaxis Inc

Healthcare


Presented:06/08/2021
Price:$8.84
Cap:$0.66B
Current Price:$1.90
Cap:$0.16B

Presented

Date06/08/2021
Price$8.84
Market Cap$0.66B
Ent Value$0.47B
P/E RatioN/A
Book Value$0.47
Div Yield0%
Shares O/S74.11M
Ave Daily Vol377,128
Short IntN/A

Current

Price$1.90
Market Cap$0.16B
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Highlights

00:00 - Introduction

00:21 - Disclaimer 

00:46 - Idea Overview

01:29 - Background on STXS

01:57 - Arrhythmia market

04:52 - STXS’ past issues 

05:41 - Why is STXS interesting now? 

07:34 - Revenue estimates

08:06 - Why did he ramp up his investment now? 

09:23 - Disposables opportunity

10:51 - Clarification on disposable revenue/royalty 

11:39 - Where he stands vs. the Street 

14:09 - The opportunity from here/valuation

15:03 - New indications 

17:32 - Comments on CEO’s salary

18:13 - Price Target

18:34 - Risks

20:00 - Niobe vs. Genesis

22:29 - STXS’ new catheter

23:37 - Concluding thoughts

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.